This is in contrast to Bolomsky et al. who have reported that PTC-209 had no impact on BIM expression and suggested that PTC-209-mediated apoptosis in MM was likely a consequence of the upregulation of NOXA and downregulation of the anti-apoptotic MCL-1 [34]. The gene discussed is MCL1; the disease is Miyoshi myopathy.